CME

Mechanisms in Chronic Myelogenous Leukemia –
Accreditation Information


Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Imedex, LLC designates the following activities for AMA PRA Category 1 Credits™,
to a maximum of:


Participants who are eligible to claim AMA PRA Category 1 Credits™ must complete the self-assessment questions and module evaluation after reviewing the content of each Learning Module.


View the complete offering
of Learning Modules

Registration Required
To access CME activities and to view your personalized CME Profile page, which tracks completed learning modules, post-test scores and CME credits earned, and allows you to download printable CME certificates.

Send us your comments
We welcome your feedback and / or questions related to the educational content provided through Mechanisms in Chronic Myelogenous Leukemia.
Hours Calculated:

A CME Review of each Learning Module was conducted to determine the credit designation for each activity. The estimated time to complete each and the credits assigned are as follows:
 Estimated Completion TimeCredit AwardedRelease DateExpiration Date
Biology and Pathophysiology of Chronic Myelogenous Leukemia 120 minutes 2.00 11/30/08 11/30/09
Clinical Manifestations and Laboratory Studies 90 minutes 1.50 11/30/08 11/30/09
Current Treatment of Chronic Myelogenous Leukemia – Imatinib and Allogeneic SCT 60 minutes 1.00 11/30/08 11/30/09
Mechanisms of Resistance 150 minutes 2.50 11/30/08 11/30/09
Treatment of Imatinib Resistant Chronic Myelogenous Leukemia 90 minutes 1.50 11/30/08 11/30/09
Monitoring of Treatment of Chronic Myelogenous Leukemia 120 minutes 2.00 11/30/08 11/30/09
Chronic Myelogenous Leukemia Treatment Guidelines 60 minutes 1.00 11/30/08 11/30/09
Questions on Management and Treatment: Side Effects and Drug Interactions 90 minutes 1.50 11/30/08 11/30/09
   13.00   

Please contact Imedex with questions related to certification.


About Us | Contact Us | Terms of Use | Privacy Policy | Technical Requirements | Site Map | Help